Cardiac rupture, mortality and the timing of thrombolytic therapy: A meta-analysis
Authors:
- Frank E. HarrellFHFrank E. Harrell
- Keith A. ReimerKRKeith A. Reimer
- Robert M. CaliffRCRobert M. Califf
- Daniel B. MarkDMDaniel B. Mark
- David B. PryorDPDavid B. Pryor
- Mark A. HlatkyMHMark A. Hlatky
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- A Randomized Trial of Intravenous Tissue Plasminogen Activator for Acute Myocardial Infarction with Subsequent Randomization to Elective Coronary AngioplastyNew England Journal of Medicine, 1987
- Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- Meta-Analyses of Randomized Controlled TrialsNew England Journal of Medicine, 1987
- A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)New England Journal of Medicine, 1986
- A Randomized Trial of Intracoronary Streptokinase in the Treatment of Acute Myocardial InfarctionNew England Journal of Medicine, 1983
- Intracoronary Fibrinolytic Therapy in Acute Myocardial InfarctionNew England Journal of Medicine, 1983
- Expansion of transmural myocardial infarction: a pathophysiologic factor in cardiac rupture.Circulation, 1979
- Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1979
- The Pathogenesis of Spontaneous Cardiac RuptureCirculation, 1952